111, Inc. income statement YI

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, 111, Inc. reported revenue of $1.8 billion, down 9.0% from the year before. It recorded a net loss of $3.2 million. The operating loss came to $340,000, an operating margin of -0.0%. Diluted earnings per share were -$0.05. Across the 8 fiscal years shown, revenue grew from $259.8 million in fiscal 2018 to $1.8 billion in fiscal 2025, about 31.8% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018
Revenue	1,795 -9.0%	1,973 -6.3%	2,105 +7.4%	1,960 +0.5%	1,950 +55.1%	1,257 +121.5%	568 +118.5%	260
Cost of revenue	1,692 -9.0%	1,859 -6.4%	1,986 +8.0%	1,838 -0.8%	1,852	—	—	—
Gross profit	103 -8.9%	114 -5.0%	120 -1.8%	122 +25.0%	97	—	—	—
Selling, general and administrative	47 -11.0%	53 -44.4%	95 -1.5%	96 -14.9%	113 +39.7%	81 +21.4%	67 +27.7%	52
Other operating income (expense)	1 -1.0%	1 +606.6%	-0 +76.2%	-1 -400.9%	0 -73.2%	1 +320.3%	-1 -452.6%	-0
Operating income	-0 -217.6%	0 +100.6%	-49 +8.3%	-54 +46.6%	-101 -38.9%	-73 -2.3%	-71 -21.7%	-58
Pretax income	-3 -13.5%	-3 +94.3%	-50 +8.8%	-55 +44.0%	-97 -36.1%	-72 +0.7%	-72 -29.7%	-56
Income tax	0 -84.6%	0 -62.9%	0	0	0	—	—	0
Net income	-3 -13.1%	-3 +94.3%	-50 +8.7%	-55 +44.0%	-97 -36.1%	-72 +0.7%	-72 -29.7%	-56
Net income to common	-9 -7.0%	-9 +84.0%	-55 +8.5%	-60 +42.5%	-105 -50.2%	-70 +2.5%	-72 -29.8%	-55
Basic EPS	-0.05 +0.0%	-0.05 +84.8%	-0.33 +8.3%	-0.36 +42.9%	-0.63	—	—	—
Diluted EPS	-0.05 +0.0%	-0.05 +84.8%	-0.33 +8.3%	-0.36 +42.9%	-0.63	—	—	—
Weighted average shares, basic	174 +1.3%	172 +1.9%	169 +1.2%	167 +0.5%	166	—	—	—
Weighted average shares, diluted	174 +1.3%	172 +1.9%	169 +1.2%	167 +0.5%	166	—	—	—
Other measures
Depreciation and amortization	2 -27.2%	2 -24.3%	3 -48.2%	6 +38.5%	4 +98.9%	2 +28.2%	2 +2.3%	2
EBITDA	1 -48.2%	3 +105.7%	-46 +3.4%	-48 +50.4%	-96 -37.1%	-70 -1.7%	-69 -22.3%	-57
Interest coverage	-0.07x	0.07x	—	—	—	—	—	—
Margins
Gross margin	5.76%	5.76%	5.68%	6.21%	5.00%	—	—	—
Operating margin	-0.02%	0.01%	-2.34%	-2.74%	-5.17%	-5.77%	-12.49%	-22.42%
Pretax margin	-0.18%	-0.14%	-2.36%	-2.78%	-5.00%	-5.69%	-12.70%	-21.39%
Profit margin	-0.18%	-0.14%	-2.36%	-2.78%	-5.00%	-5.69%	-12.70%	-21.39%
EBITDA margin	0.08%	0.13%	-2.20%	-2.44%	-4.95%	-5.60%	-12.19%	-21.79%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as: YI (Nasdaq)
Fiscal year ends: December 31
Incorporated in: Cayman Islands
Headquarters: Shanghai
SEC filer status: Non-accelerated filer
SEC CIK: 1738906

Other Retail-Drug Stores and Proprietary Stores companies

All 6 Retail-Drug Stores and Proprietary Stores companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.